Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome.

Saved in:
Bibliographic Details
Title: Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome.
Authors: Talbot A; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris. alexis.talbot@aphp.fr., Forgeard N; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Vaugeois T; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Theves F; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Dimassi S; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Royer B; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Debureaux PE; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris., Meignin V; Department of Pathology, Saint-Louis Hospital, AP-HP, Paris., Vercellino L; Université Paris Cité, Paris, France; Department of Nuclear Medicine, Saint Louis Hospital, AP-HP, Paris., Boutboul D; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris., Arnulf B; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris., Harel S; Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris.
Source: Haematologica [Haematologica] 2026 Apr 01; Vol. 111 (4), pp. 1490-1493. Date of Electronic Publication: 2025 Jul 03.
Publication Type: Journal Article
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1592-8721
DOI:10.3324/haematol.2025.287606